ES2183583T3 - Agente con efecto antidepresivo, que contiene pramipexol y sertralina. - Google Patents
Agente con efecto antidepresivo, que contiene pramipexol y sertralina.Info
- Publication number
- ES2183583T3 ES2183583T3 ES99934560T ES99934560T ES2183583T3 ES 2183583 T3 ES2183583 T3 ES 2183583T3 ES 99934560 T ES99934560 T ES 99934560T ES 99934560 T ES99934560 T ES 99934560T ES 2183583 T3 ES2183583 T3 ES 2183583T3
- Authority
- ES
- Spain
- Prior art keywords
- sertraline
- agent
- pramipexol
- antidepressive effect
- antidepressive
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- VGKDLMBJGBXTGI-SJCJKPOMSA-N sertraline Chemical compound C1([C@@H]2CC[C@@H](C3=CC=CC=C32)NC)=CC=C(Cl)C(Cl)=C1 VGKDLMBJGBXTGI-SJCJKPOMSA-N 0.000 title abstract 2
- 229960002073 sertraline Drugs 0.000 title abstract 2
- 230000001430 anti-depressive effect Effects 0.000 title 1
- FASDKYOPVNHBLU-ZETCQYMHSA-N pramipexole Chemical compound C1[C@@H](NCCC)CCC2=C1SC(N)=N2 FASDKYOPVNHBLU-ZETCQYMHSA-N 0.000 title 1
- 150000003839 salts Chemical class 0.000 abstract 2
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 abstract 1
- 208000020401 Depressive disease Diseases 0.000 abstract 1
- FASDKYOPVNHBLU-UHFFFAOYSA-N N6-Propyl-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine Chemical compound C1C(NCCC)CCC2=C1SC(N)=N2 FASDKYOPVNHBLU-UHFFFAOYSA-N 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 150000007513 acids Chemical class 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19830201A DE19830201A1 (de) | 1998-07-07 | 1998-07-07 | Mittel mit antidepressiver Wirkung |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2183583T3 true ES2183583T3 (es) | 2003-03-16 |
Family
ID=7873155
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES99934560T Expired - Lifetime ES2183583T3 (es) | 1998-07-07 | 1999-07-02 | Agente con efecto antidepresivo, que contiene pramipexol y sertralina. |
Country Status (32)
| Country | Link |
|---|---|
| US (1) | US6255329B1 (https=) |
| EP (1) | EP1093369B1 (https=) |
| JP (1) | JP2002520273A (https=) |
| KR (1) | KR100557692B1 (https=) |
| CN (1) | CN1230168C (https=) |
| AR (1) | AR019896A1 (https=) |
| AT (1) | ATE228365T1 (https=) |
| AU (1) | AU762128B2 (https=) |
| BG (1) | BG64972B1 (https=) |
| BR (1) | BR9911768A (https=) |
| CA (1) | CA2336833C (https=) |
| CZ (1) | CZ294087B6 (https=) |
| DE (2) | DE19830201A1 (https=) |
| DK (1) | DK1093369T3 (https=) |
| EA (1) | EA003142B1 (https=) |
| EE (1) | EE04296B1 (https=) |
| ES (1) | ES2183583T3 (https=) |
| HU (1) | HUP0103922A3 (https=) |
| ID (1) | ID27776A (https=) |
| IL (1) | IL140603A0 (https=) |
| MY (1) | MY117969A (https=) |
| NO (1) | NO20010064L (https=) |
| NZ (1) | NZ509729A (https=) |
| PL (1) | PL195043B1 (https=) |
| PT (1) | PT1093369E (https=) |
| RS (1) | RS49795B (https=) |
| SK (1) | SK284923B6 (https=) |
| TR (1) | TR200100146T2 (https=) |
| TW (1) | TW592698B (https=) |
| WO (1) | WO2000002542A2 (https=) |
| YU (1) | YU401A (https=) |
| ZA (1) | ZA200100090B (https=) |
Families Citing this family (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2000006162A1 (de) * | 1998-07-27 | 2000-02-10 | Boehringer Ingelheim Pharma Kg | Mittel mit antidepressiver wirkung, mit pramipexol und einem weiteren antidepressivum |
| US20020165246A1 (en) * | 2001-03-05 | 2002-11-07 | Andrew Holman | Administration of sleep restorative agents |
| DE10138275A1 (de) * | 2001-08-10 | 2003-02-27 | Boehringer Ingelheim Pharma | Verbindungen zur Beseitigung der Anhedonie |
| ES2432527T3 (es) * | 2001-12-11 | 2013-12-04 | University Of Virginia Patent Foundation | Uso de pramipexol para tratar la esclerosis lateral amiotrófica |
| US20060281797A1 (en) * | 2001-12-11 | 2006-12-14 | University Of Virginia Patent Foundation | Neurorestoration with R(+) Pramipexole |
| DE10334187A1 (de) * | 2003-07-26 | 2005-03-03 | Schwarz Pharma Ag | Substituierte 2-Aminotetraline zur Behandlung von Depressionen |
| DE10334188B4 (de) * | 2003-07-26 | 2007-07-05 | Schwarz Pharma Ag | Verwendung von Rotigotin zur Behandlung von Depressionen |
| WO2005070428A1 (en) * | 2004-01-22 | 2005-08-04 | Boehringer Ingelheim International Gmbh | Pharmaceutical composition comprising a monoamine neurotransmitter re-uptake inhibitor and a dopamine agonist |
| WO2007022182A1 (en) * | 2005-08-15 | 2007-02-22 | University Of Virginia Patent Foundation | Neurorestoration with r(+) pramipexole |
| US8518926B2 (en) | 2006-04-10 | 2013-08-27 | Knopp Neurosciences, Inc. | Compositions and methods of using (R)-pramipexole |
| ES2379117T3 (es) | 2006-05-16 | 2012-04-20 | Knopp Neurosciences, Inc. | Composiciones de R(+) y S(-) pramipexol y métodos de utilización de las mismas |
| US20080254118A1 (en) * | 2007-04-11 | 2008-10-16 | Hans-Werner Wernersbach | Process for preparing pramipexole dihydrochloride tablets |
| US8524695B2 (en) | 2006-12-14 | 2013-09-03 | Knopp Neurosciences, Inc. | Modified release formulations of (6R)-4,5,6,7-tetrahydro-N6-propyl-2,6-benzothiazole-diamine and methods of using the same |
| CA2681110A1 (en) | 2007-03-14 | 2008-09-18 | Knopp Neurosciences, Inc. | Synthesis of chirally purified substituted benzothiazole diamines |
| US20080254117A1 (en) * | 2007-04-10 | 2008-10-16 | Noel Cotton | Process for preparing pramipexole dihydrochloride tablets |
| KR20110071064A (ko) * | 2008-08-19 | 2011-06-28 | 크놉 뉴로사이언시스 인코포레이티드 | (ｒ)-프라미펙솔을 사용하는 조성물 및 방법 |
| EP2341912B1 (en) | 2008-09-05 | 2014-01-22 | Supernus Pharmaceuticals, Inc. | Method of treatment of attention deficit/hyperactivity disorder (adhd) |
| JP2012525426A (ja) * | 2009-04-30 | 2012-10-22 | スパーナス ファーマシューティカルズ インコーポレイテッド | うつ病を治療する方法 |
| WO2013096816A1 (en) | 2011-12-22 | 2013-06-27 | Biogen Idec Ma Inc. | Improved synthesis of amine substituted 4,5,6,7-tetrahydrobenzothiazole compounds |
| AU2013217013B2 (en) | 2012-02-08 | 2017-04-20 | Supernus Pharmaceuticals, Inc. | Modified release formulations of viloxazine |
| US9662313B2 (en) | 2013-02-28 | 2017-05-30 | Knopp Biosciences Llc | Compositions and methods for treating amyotrophic lateral sclerosis in responders |
| US9468630B2 (en) | 2013-07-12 | 2016-10-18 | Knopp Biosciences Llc | Compositions and methods for treating conditions related to increased eosinophils |
| EP3838271B1 (en) | 2013-07-12 | 2025-09-03 | Areteia Therapeutics, Inc. | Treating elevated levels of eosinophils and/or basophils |
| ES2813674T3 (es) | 2013-08-13 | 2021-03-24 | Knopp Biosciences Llc | Composiciones y métodos para el tratamiento de trastornos de células plasmáticas y trastornos prolinfocíticos de células b |
| CA2921381A1 (en) | 2013-08-13 | 2015-02-19 | Knopp Biosciences Llc | Compositions and methods for treating chronic urticaria |
| IL312486B2 (en) * | 2017-04-10 | 2025-05-01 | Chase Therapeutics Corp | NK1 antagonist combination and method for treating synucleinopathies |
| CN121221782A (zh) | 2017-06-30 | 2025-12-30 | 傲拓神经科学公司 | 用于治疗抑郁的nk-1拮抗剂组合物和方法 |
| CN110028464B (zh) * | 2019-04-26 | 2022-11-18 | 浙江海洋大学 | 一种南极真菌次级代谢衍生物BTZ-one及其制备方法和应用 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4536518A (en) * | 1979-11-01 | 1985-08-20 | Pfizer Inc. | Antidepressant derivatives of cis-4-phenyl-1,2,3,4-tetrahydro-1-naphthalenamine |
| ATE45735T1 (de) * | 1984-12-22 | 1989-09-15 | Thomae Gmbh Dr K | Tetrahydro-benzthiazole, deren herstellung und deren verwendung als zwischenprodukte oder als arnzneimittel. |
| DE3843227A1 (de) * | 1988-12-22 | 1990-07-05 | Boehringer Ingelheim Kg | Neue verwendung von 2-amino-6-n-propylamino-4,5,6,7-tetrahydrobenzthiazol |
| US4962128A (en) * | 1989-11-02 | 1990-10-09 | Pfizer Inc. | Method of treating anxiety-related disorders using sertraline |
| DE3937271A1 (de) * | 1989-11-09 | 1991-05-16 | Boehringer Ingelheim Kg | Transdermale applikation von 2-amino-6-n-propylamino-4,5,6,7-tetrahydrobenzothiazol |
| US5248699A (en) * | 1992-08-13 | 1993-09-28 | Pfizer Inc. | Sertraline polymorph |
| DE4241013A1 (de) * | 1992-12-05 | 1994-06-09 | Boehringer Ingelheim Kg | Verwendung von 2-Amino-6-n-propyl-amino-4,5,6,7-tetrahydrobenzothiazol als Arzneimittel mit antidepressiver Wirkung |
| JP3947582B2 (ja) * | 1995-08-15 | 2007-07-25 | 中外製薬株式会社 | 不安神経症治療剤 |
| NZ325914A (en) * | 1996-03-29 | 1999-09-29 | Pfizer | Benzyl(idene)-lactam derivatives and salts thereof, their preparation and their use as selective (ant)agonists of 5-ht1a and/or 5-ht1d receptors and thus are effective as psychotherapeutic agents |
| ATE282417T1 (de) * | 1996-12-02 | 2004-12-15 | Merck Sharp & Dohme | Die verwendung von nk-1 rezeptor antagonisten für die behandlung von bewegungsstörungen |
| WO1999036064A2 (en) * | 1998-01-13 | 1999-07-22 | Synchroneuron, Llc | Methods of treating tardive dyskinesia and other movement disorders |
-
1998
- 1998-07-07 DE DE19830201A patent/DE19830201A1/de not_active Withdrawn
-
1999
- 1999-07-02 HU HU0103922A patent/HUP0103922A3/hu unknown
- 1999-07-02 WO PCT/EP1999/004595 patent/WO2000002542A2/de not_active Ceased
- 1999-07-02 PL PL99345842A patent/PL195043B1/pl not_active IP Right Cessation
- 1999-07-02 EA EA200100084A patent/EA003142B1/ru not_active IP Right Cessation
- 1999-07-02 CZ CZ200177A patent/CZ294087B6/cs not_active IP Right Cessation
- 1999-07-02 DE DE59903556T patent/DE59903556D1/de not_active Expired - Fee Related
- 1999-07-02 DK DK99934560T patent/DK1093369T3/da active
- 1999-07-02 RS YUP-4/01A patent/RS49795B/sr unknown
- 1999-07-02 YU YU401A patent/YU401A/sh unknown
- 1999-07-02 IL IL14060399A patent/IL140603A0/xx not_active IP Right Cessation
- 1999-07-02 ES ES99934560T patent/ES2183583T3/es not_active Expired - Lifetime
- 1999-07-02 EP EP99934560A patent/EP1093369B1/de not_active Expired - Lifetime
- 1999-07-02 ID IDW20010017A patent/ID27776A/id unknown
- 1999-07-02 SK SK11-2001A patent/SK284923B6/sk not_active IP Right Cessation
- 1999-07-02 CA CA002336833A patent/CA2336833C/en not_active Expired - Fee Related
- 1999-07-02 TR TR2001/00146T patent/TR200100146T2/xx unknown
- 1999-07-02 NZ NZ509729A patent/NZ509729A/xx unknown
- 1999-07-02 CN CNB998083038A patent/CN1230168C/zh not_active Expired - Fee Related
- 1999-07-02 AT AT99934560T patent/ATE228365T1/de not_active IP Right Cessation
- 1999-07-02 KR KR1020017000088A patent/KR100557692B1/ko not_active Expired - Fee Related
- 1999-07-02 PT PT99934560T patent/PT1093369E/pt unknown
- 1999-07-02 AU AU50303/99A patent/AU762128B2/en not_active Ceased
- 1999-07-02 BR BR9911768-1A patent/BR9911768A/pt not_active Application Discontinuation
- 1999-07-02 JP JP2000558802A patent/JP2002520273A/ja active Pending
- 1999-07-02 EE EEP200100014A patent/EE04296B1/xx not_active IP Right Cessation
- 1999-07-06 US US09/348,591 patent/US6255329B1/en not_active Expired - Fee Related
- 1999-07-06 TW TW088111454A patent/TW592698B/zh not_active IP Right Cessation
- 1999-07-07 AR ARP990103294A patent/AR019896A1/es unknown
- 1999-07-07 MY MYPI99002869A patent/MY117969A/en unknown
-
2001
- 2001-01-03 BG BG105112A patent/BG64972B1/bg unknown
- 2001-01-04 ZA ZA200100090A patent/ZA200100090B/en unknown
- 2001-01-05 NO NO20010064A patent/NO20010064L/no not_active Application Discontinuation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2183583T3 (es) | Agente con efecto antidepresivo, que contiene pramipexol y sertralina. | |
| AR023529A1 (es) | Una composicion champu acondicionadora del cabello y un metodo para acondicionar el cabello | |
| ECSP056229A (es) | Una composición farmacéutica que comprende formas polimórficas de 3-(4-amino-1-oxo-1.3 dyhidro-isoindol-2-il)-piperidina-2,6-diona para el tratamiento y manejo de cánceres | |
| AR064901A2 (es) | Una pelicula consumible adaptada para disolverse en la boca de un consumidor | |
| AR010348A1 (es) | Cetobenzamidas, su utilizacion y composicion farmeceutica que las contienen | |
| ES2100100T3 (es) | Composicion para aplicacion topica que contiene una lipasa y un precursor de agente activo. | |
| CO5150154A1 (es) | Composicion de sustrato y metodo para usarlo para el secuestro de irritantes de la piel | |
| BR0114628A (pt) | Membro de retenção em microprojeção para aplicador de impacto | |
| UY26850A1 (es) | Activadores de la benzeno acetamida glucoquinasa alfa-acil y alfa-heteroátomo sustituida. | |
| ATE504557T1 (de) | Aspirin-ausgelöste lipidmediatoren | |
| AR046970A1 (es) | Esteres de fosfato de florfenicol | |
| ECSP055738A (es) | PROCESO ENANTIOSELECTIVO PARA LA PREPARACIÓN DE AMBOS ENANTIÓMEROS DE 10,11-DIHIDRO-10-HIDROXI-5H-DIBENZ-[b,f]-AZEPIN-5-CARBOXAMIDA Y SUS NUEVAS FORMAS DE CRISTAL | |
| ES2526912T3 (es) | Composición farmacéutica que contiene neurotoxina botulínica A2 | |
| AR034200A1 (es) | Agente para el cuidado de lentes de contacto, su uso, y procedimiento de limpieza | |
| AR043660A1 (es) | El tratamiento de la enfermedad de alzheimer | |
| CR9385A (es) | Agente preventivo o terapeutico para el desorden de la depresion o la ansiedad | |
| BRPI0507530A (pt) | preparação para liberação prolongada, agente para evitar ou tratar doença, processo para produzir a preparação para liberação prolongada, método para evitar ou tratar doença, e, uso da preparação para liberação prolongada | |
| ES2193065T3 (es) | Nueva utilizacion del saredutant. | |
| BR0308170A (pt) | Composição para limpeza lìquida aquosa, método para limpeza de um substrato, e, uso de um polioxometalato | |
| ES2065307T3 (es) | Producto y procedimiento para el moldeado permanente del cabello. | |
| MY146561A (en) | Oral care instrument including an oral care agent | |
| ES2486844T3 (es) | Sustancia que presenta propiedad antidepresiva | |
| MX9405371A (es) | Derivado de naftilo. | |
| ES2178200T3 (es) | Conservante para lentes de contacto, solido y soluble en agua. | |
| BRPI0506631A (pt) | combinações de um agente antiemético, composição farmacêutica e usos das combinações |